The Prognostic Value of Soluble ST2 in Adults with Pulmonary Hypertension

Soluble ST2 (sST2) is upregulated in response to myocardial stress and may serve as biomarker in adults with pulmonary hypertension (PH). This prospective cohort study investigated sST2 levels and its association with echocardiographic and hemodynamic measures, and adverse clinical outcomes in adult...

Full description

Bibliographic Details
Main Authors: Laurie W. Geenen, Vivan J. M. Baggen, Robert M. Kauling, Thomas Koudstaal, Karin A. Boomars, Eric Boersma, Jolien W. Roos-Hesselink, Annemien E. van den Bosch
Format: Article
Language:English
Published: MDPI AG 2019-09-01
Series:Journal of Clinical Medicine
Subjects:
ST2
Online Access:https://www.mdpi.com/2077-0383/8/10/1517
id doaj-2acaa20d39ea4b46b6cabce98a4e63d1
record_format Article
spelling doaj-2acaa20d39ea4b46b6cabce98a4e63d12020-11-24T22:14:35ZengMDPI AGJournal of Clinical Medicine2077-03832019-09-01810151710.3390/jcm8101517jcm8101517The Prognostic Value of Soluble ST2 in Adults with Pulmonary HypertensionLaurie W. Geenen0Vivan J. M. Baggen1Robert M. Kauling2Thomas Koudstaal3Karin A. Boomars4Eric Boersma5Jolien W. Roos-Hesselink6Annemien E. van den Bosch7Department of Cardiology, Erasmus University Medical Center, 3015 GD Rotterdam, The NetherlandsDepartment of Cardiology, Erasmus University Medical Center, 3015 GD Rotterdam, The NetherlandsDepartment of Cardiology, Erasmus University Medical Center, 3015 GD Rotterdam, The NetherlandsDepartment of Pulmonary Medicine, Erasmus University Medical Center, 3015 GD Rotterdam, The NetherlandsDepartment of Pulmonary Medicine, Erasmus University Medical Center, 3015 GD Rotterdam, The NetherlandsDepartment of Cardiology, Erasmus University Medical Center, 3015 GD Rotterdam, The NetherlandsDepartment of Cardiology, Erasmus University Medical Center, 3015 GD Rotterdam, The NetherlandsDepartment of Cardiology, Erasmus University Medical Center, 3015 GD Rotterdam, The NetherlandsSoluble ST2 (sST2) is upregulated in response to myocardial stress and may serve as biomarker in adults with pulmonary hypertension (PH). This prospective cohort study investigated sST2 levels and its association with echocardiographic and hemodynamic measures, and adverse clinical outcomes in adults with PH of different etiologies. sST2 was measured during the diagnostic right heart catheterization for PH, in adult patients enrolled between May 2012 and October 2016. PH due to left heart failure was excluded. The association between sST2 and a primary endpoint composed of death or lung transplantation and a secondary composite endpoint including death, lung transplantation or heart failure, was investigated using Cox regression with adjustment for NT-proBNP. In total 104 patients were included (median age was 59 years, 66% woman, 51% pulmonary arterial hypertension). Median sST2 was 28 [IQR 20&#8722;46] ng/mL. Higher sST2 was associated with worse right ventricular dysfunction and higher mean pulmonary and right atrial pressures. Median follow-up was 3.3 [IQR 2.3&#8722;4.6] years. The primary and secondary endpoint occurred in 33 (31.7%) and 43 (41.3%) patients, respectively. sST2 was significantly associated with both endpoints (HR per 2-fold higher value 1.53, 95%CI 1.12&#8722;2.07, <i>p</i> = 0.007 and 1.45, 95%CI 1.10&#8722;1.90, <i>p</i> = 0.008, respectively). However, after adjustment for NT-proBNP, both associations did not reach statistical significance. In conclusions, higher sST2 levels are associated with more severe PH and right ventricular dysfunction and yields prognostic value in adults with PH, although not independently of NT-proBNP.https://www.mdpi.com/2077-0383/8/10/1517ST2pulmonary hypertensionbiomarkers
collection DOAJ
language English
format Article
sources DOAJ
author Laurie W. Geenen
Vivan J. M. Baggen
Robert M. Kauling
Thomas Koudstaal
Karin A. Boomars
Eric Boersma
Jolien W. Roos-Hesselink
Annemien E. van den Bosch
spellingShingle Laurie W. Geenen
Vivan J. M. Baggen
Robert M. Kauling
Thomas Koudstaal
Karin A. Boomars
Eric Boersma
Jolien W. Roos-Hesselink
Annemien E. van den Bosch
The Prognostic Value of Soluble ST2 in Adults with Pulmonary Hypertension
Journal of Clinical Medicine
ST2
pulmonary hypertension
biomarkers
author_facet Laurie W. Geenen
Vivan J. M. Baggen
Robert M. Kauling
Thomas Koudstaal
Karin A. Boomars
Eric Boersma
Jolien W. Roos-Hesselink
Annemien E. van den Bosch
author_sort Laurie W. Geenen
title The Prognostic Value of Soluble ST2 in Adults with Pulmonary Hypertension
title_short The Prognostic Value of Soluble ST2 in Adults with Pulmonary Hypertension
title_full The Prognostic Value of Soluble ST2 in Adults with Pulmonary Hypertension
title_fullStr The Prognostic Value of Soluble ST2 in Adults with Pulmonary Hypertension
title_full_unstemmed The Prognostic Value of Soluble ST2 in Adults with Pulmonary Hypertension
title_sort prognostic value of soluble st2 in adults with pulmonary hypertension
publisher MDPI AG
series Journal of Clinical Medicine
issn 2077-0383
publishDate 2019-09-01
description Soluble ST2 (sST2) is upregulated in response to myocardial stress and may serve as biomarker in adults with pulmonary hypertension (PH). This prospective cohort study investigated sST2 levels and its association with echocardiographic and hemodynamic measures, and adverse clinical outcomes in adults with PH of different etiologies. sST2 was measured during the diagnostic right heart catheterization for PH, in adult patients enrolled between May 2012 and October 2016. PH due to left heart failure was excluded. The association between sST2 and a primary endpoint composed of death or lung transplantation and a secondary composite endpoint including death, lung transplantation or heart failure, was investigated using Cox regression with adjustment for NT-proBNP. In total 104 patients were included (median age was 59 years, 66% woman, 51% pulmonary arterial hypertension). Median sST2 was 28 [IQR 20&#8722;46] ng/mL. Higher sST2 was associated with worse right ventricular dysfunction and higher mean pulmonary and right atrial pressures. Median follow-up was 3.3 [IQR 2.3&#8722;4.6] years. The primary and secondary endpoint occurred in 33 (31.7%) and 43 (41.3%) patients, respectively. sST2 was significantly associated with both endpoints (HR per 2-fold higher value 1.53, 95%CI 1.12&#8722;2.07, <i>p</i> = 0.007 and 1.45, 95%CI 1.10&#8722;1.90, <i>p</i> = 0.008, respectively). However, after adjustment for NT-proBNP, both associations did not reach statistical significance. In conclusions, higher sST2 levels are associated with more severe PH and right ventricular dysfunction and yields prognostic value in adults with PH, although not independently of NT-proBNP.
topic ST2
pulmonary hypertension
biomarkers
url https://www.mdpi.com/2077-0383/8/10/1517
work_keys_str_mv AT lauriewgeenen theprognosticvalueofsolublest2inadultswithpulmonaryhypertension
AT vivanjmbaggen theprognosticvalueofsolublest2inadultswithpulmonaryhypertension
AT robertmkauling theprognosticvalueofsolublest2inadultswithpulmonaryhypertension
AT thomaskoudstaal theprognosticvalueofsolublest2inadultswithpulmonaryhypertension
AT karinaboomars theprognosticvalueofsolublest2inadultswithpulmonaryhypertension
AT ericboersma theprognosticvalueofsolublest2inadultswithpulmonaryhypertension
AT jolienwrooshesselink theprognosticvalueofsolublest2inadultswithpulmonaryhypertension
AT annemienevandenbosch theprognosticvalueofsolublest2inadultswithpulmonaryhypertension
AT lauriewgeenen prognosticvalueofsolublest2inadultswithpulmonaryhypertension
AT vivanjmbaggen prognosticvalueofsolublest2inadultswithpulmonaryhypertension
AT robertmkauling prognosticvalueofsolublest2inadultswithpulmonaryhypertension
AT thomaskoudstaal prognosticvalueofsolublest2inadultswithpulmonaryhypertension
AT karinaboomars prognosticvalueofsolublest2inadultswithpulmonaryhypertension
AT ericboersma prognosticvalueofsolublest2inadultswithpulmonaryhypertension
AT jolienwrooshesselink prognosticvalueofsolublest2inadultswithpulmonaryhypertension
AT annemienevandenbosch prognosticvalueofsolublest2inadultswithpulmonaryhypertension
_version_ 1725798159511191552